Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M343,170Revenue (TTM) $M70,877Net Margin (%)21.0Altman Z-Score5.7
Enterprise Value $M326,664EPS (TTM) $5.3Operating Margin %26.7Piotroski F-Score6
P/E(ttm)23.4Beneish M-Score-2.6Pre-tax Margin (%)25.5Higher ROA y-yY
Price/Book4.710-y EBITDA Growth Rate %4.0Quick Ratio2.5Cash flow > EarningsY
Price/Sales5.05-y EBITDA Growth Rate %5.9Current Ratio2.8Lower Leverage y-yN
Price/Free Cash Flow24.0y-y EBITDA Growth Rate %-13.8ROA % (ttm)11.2Higher Current Ratio y-yY
Dividend Yield %2.4PEG3.9ROE % (ttm)21.0Less Shares Outstanding y-yY
Payout Ratio %55.0Shares Outstanding M2,751ROIC % (ttm)28.3Gross Margin Increase y-yN

Gurus Latest Trades with JNJ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JNJYacktman Focused Fund 2016-06-30 Reduce-0.87%$108.2 - $121.3
($113.54)
$ 125.1510%Reduce -15.22%1,950,000
JNJT Rowe Price Equity Income Fund 2016-06-30 Reduce-0.28%$108.2 - $121.3
($113.54)
$ 125.1510%Reduce -14.17%3,400,000
JNJTweedy Browne 2016-03-31 Reduce-0.93%$95.75 - $109.14
($103.39)
$ 125.1521%Reduce -8.39%3,383,445
JNJFirst Eagle Investment 2016-03-31 Reduce-0.49%$95.75 - $109.14
($103.39)
$ 125.1521%Reduce -62.31%1,142,872
JNJYacktman Focused Fund 2016-03-31 Reduce-0.45%$95.75 - $109.14
($103.39)
$ 125.1521%Reduce -8.00%2,300,000
JNJT Rowe Price Equity Income Fund 2016-03-31 Reduce-0.33%$95.75 - $109.14
($103.39)
$ 125.1521%Reduce -15.23%3,961,300
JNJRobert Olstein 2016-03-31 Reduce-0.28%$95.75 - $109.14
($103.39)
$ 125.1521%Reduce -29.58%50,000
JNJJoel Greenblatt 2016-03-31 Add0.24%$95.75 - $109.14
($103.39)
$ 125.1521%Add 511.44%242,043
JNJDonald Yacktman 2016-03-31 Reduce-0.18%$95.75 - $109.14
($103.39)
$ 125.1521%Reduce -3.22%7,080,500
JNJRuane Cunniff 2016-03-31 Reduce-0.03%$95.75 - $109.14
($103.39)
$ 125.1521%Reduce -78.50%13,925
JNJJohn Rogers 2016-03-31 Add0.03%$95.75 - $109.14
($103.39)
$ 125.1521%Add 2.31%850,915
JNJTom Gayner 2016-03-31 Add0.02%$95.75 - $109.14
($103.39)
$ 125.1521%Add 0.93%610,800
JNJRichard Pzena 2016-03-31 Add0.01%$95.75 - $109.14
($103.39)
$ 125.1521%Add 0.92%1,185,329
JNJKen Fisher 2016-03-31 Add0.01%$95.75 - $109.14
($103.39)
$ 125.1521%Add 0.35%10,854,263
JNJCharles Brandes 2016-03-31 Reduce-0.01%$95.75 - $109.14
($103.39)
$ 125.1521%Reduce -3.20%146,253
JNJMario Gabelli 2016-03-31 Add$95.75 - $109.14
($103.39)
$ 125.1521%Add 1.60%337,588
JNJBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Reduce$95.75 - $109.14
($103.39)
$ 125.1521%Reduce -0.10%15,327,465
JNJDodge & Cox 2016-03-31 Reduce$95.75 - $109.14
($103.39)
$ 125.1521%Reduce -1.77%34,808
JNJTweedy Browne 2015-12-31 Reduce-0.45%$93.42 - $105.25
($100.75)
$ 125.1524%Reduce -4.22%3,693,349
JNJFirst Eagle Investment 2015-12-31 Add0.37%$93.42 - $105.25
($100.75)
$ 125.1524%Add 91.19%3,032,177
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JNJ is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


JNJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Kapusta Ronald AController, CAO 2016-07-22Sell2,935$125.010.11view
Pruden Gary JExec VP, WW Chair, Med Devices 2016-06-07Sell9,735$116.037.86view
Kapusta Ronald AController, CAO 2016-06-07Sell3,000$115.798.08view
Kapusta Ronald AController, CAO 2016-05-10Sell3,957$114.779.04view
Stoffels PaulusChief Scientific Officer 2016-02-17Sell125,000$102.4322.18view
Fasolo PeterVP, Global Human Resources 2016-02-03Sell151,385$104.1220.2view
Ullmann Michael HVP, General Counsel 2015-11-20Sell17,650$102.4722.13view
Caruso Dominic JVP, Finance; CFO 2015-11-02Sell20,569$102.2122.44view
Kapusta Ronald AController, CAO 2015-10-23Sell6,239$99.6825.55view
PRINCE CHARLESDirector 2015-08-06Buy2,500$99.2526.1view

Press Releases about JNJ :

Quarterly/Annual Reports about JNJ:

    News about JNJ:

    Articles On GuruFocus.com
    Companies Hit 52-Week Highs Jul 26 2016 
    UnitedHealth Reports 28% Sales Growth in 2nd Quarter Jul 23 2016 
    Johnson & Johnson Reports 4% Sales Growth for the Second Quarter Jul 22 2016 
    T. Rowe Price Equity Income Fund Sells Apache, Johnson & Johnson in 2nd Quarter Jul 21 2016 
    What Will Happen to the Stock Market When Interest Rates Rise? Part 1 Jul 21 2016 
    Microsoft in Focus as Stock Valuation Gains Ease Slightly Jul 19 2016 
    Yacktman Focused Fund, Focuses Elsewhere Jul 19 2016 
    Can the Procter & Gamble’s Find Its Lost Mojo? Jul 19 2016 
    Why Berkshire Hathaway Dumped Johnson & Johnson Jul 19 2016 
    Avoid Getting Sucked In at the Top Jul 17 2016 

    More From Other Websites
    Will MNK’s Segmental Growth Result in a 3Q16 Earnings Surprise? Jul 26 2016
    FDA enhances warnings on group of strong antibiotics Jul 26 2016
    Top 10 Dividend Aristocrats to Buy at a Discount Now Jul 26 2016
    Companies Hit 52-Week Highs Jul 26 2016
    Tokai's shares tumble as it halts prostate-cancer drug trial Jul 26 2016
    What to Expect from Zimmer Biomet Holdings’ 2Q16 Earnings Jul 26 2016
    Janssen Announces Clinical Collaboration with Bristol-Myers Squibb to Evaluate Immuno-oncology... Jul 26 2016
    What’s Johnson & Johnson’s Guidance for 2016? Jul 26 2016
    5 Best Stocks to Buy for the Next 50 Years Jul 26 2016
    What Key Developments Did JNJ Announce in 2Q16? Jul 26 2016
    The Death Of Brand Loyalty: Cultural Shifts Mean It's Gone Forever Jul 25 2016
    Is Johnson & Johnson ready for pullback? Jul 25 2016
    How Did JNJ’s Medical Devices Segment Perform in 2Q16? Jul 25 2016
    Analysts’ Recommendations for JNJ after 2Q16 Earnings Jul 25 2016
    The Zacks Analyst Blog Highlights: Bank of America, Chevron, Exxon Mobil, Johnson & Johnson and... Jul 25 2016
    How Did Johnson & Johnson’s Consumer Segment Perform in 2Q16? Jul 25 2016
    How Did JNJ’s Medical Devices Business Fare in 2Q16? Jul 25 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)